Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).
Saved in:
| Title: | Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)). |
|---|---|
| Authors: | Hsu A; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA., Yao HM; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA., Gupta S; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA., Modi NB; Impax Specialty Pharma, a division of Impax Laboratories, Inc., Hayward, CA, USA. |
| Source: | Journal of clinical pharmacology [J Clin Pharmacol] 2015 Sep; Vol. 55 (9), pp. 995-1003. Date of Electronic Publication: 2015 May 20. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
